209 related articles for article (PubMed ID: 24317363)
1. miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.
Yu J; Lu Y; Cui D; Li E; Zhu Y; Zhao Y; Zhao F; Xia S
Oncol Rep; 2014 Feb; 31(2):910-8. PubMed ID: 24317363
[TBL] [Abstract][Full Text] [Related]
2. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
3. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
5. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.
Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C
Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133
[TBL] [Abstract][Full Text] [Related]
6. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
Xiang J; Bian C; Wang H; Huang S; Wu D
J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
Xia L; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W; Sha J
Biomed Pharmacother; 2020 Apr; 124():109863. PubMed ID: 31986411
[TBL] [Abstract][Full Text] [Related]
8. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.
Xu B; Niu X; Zhang X; Tao J; Wu D; Wang Z; Li P; Zhang W; Wu H; Feng N; Wang Z; Hua L; Wang X
Mol Cell Biochem; 2011 Apr; 350(1-2):207-13. PubMed ID: 21197560
[TBL] [Abstract][Full Text] [Related]
9. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
12. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells.
Huang S; Guo W; Tang Y; Ren D; Zou X; Peng X
Oncol Rep; 2012 Nov; 28(5):1831-7. PubMed ID: 22948942
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.
Feng B; Wang R; Song HZ; Chen LB
Cancer; 2012 Jul; 118(13):3365-76. PubMed ID: 22139708
[TBL] [Abstract][Full Text] [Related]
15. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
Liu S; Tetzlaff MT; Cui R; Xu X
Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
[TBL] [Abstract][Full Text] [Related]
16. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
17. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
[TBL] [Abstract][Full Text] [Related]
18. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
Guo S; Xu X; Tang Y; Zhang C; Li J; Ouyang Y; Ju J; Bie P; Wang H
Cancer Lett; 2014 Mar; 344(1):40-46. PubMed ID: 24252251
[TBL] [Abstract][Full Text] [Related]
19. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
[TBL] [Abstract][Full Text] [Related]
20. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
